Prosensa announces commencement of redosing of drisapersen in North America in patients with Duchenne muscular dystrophy Leiden, The Netherlands, Sept. 17, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA), th

First Page		Document Content
Date: 2014-09-22 14:00:28 Chemistry Duchenne muscular dystrophy Dystrophin Clinical trial Methadone Muscular dystrophy Health Biology		Prosensa announces commencement of redosing of drisapersen in North America in patients with Duchenne muscular dystrophy Leiden, The Netherlands, Sept. 17, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA), th Add to Reading List Source URL: muscle.ca Download Document from Source Website File Size: 87,60 KB Share Document on Facebook

	Microsoft Word - Joint Advisory Opinion by the BME BON and BOP regarding Methadone Clinics DocID: 1varW - View Document
	Methadone Dosing Guideline DocID: 1v2ad - View Document
	Methadone Treatment and Services Advisory Committee Final Report June 9, 2016 DocID: 1t4Ca - View Document
	Overdose Prevention Overdoses from opioid drugs (drugs like heroin, methadone, morphine, and fentanyl) have been on the rise in B.C. Opioid overdoses are very serious and can result in death. If you or someone you know i DocID: 1sUWu - View Document
	INSTRUCTIONS TO COMMENT DATES: To be assured consideration, comments must be received at one of the ADDRESSES provided below, no later than 5 p.m. on Monday, April 11, 2016. In commenting, please refer to file code SAMHS DocID: 1si22 - View Document